MEDP
NASDAQMedpace Holdings Inc.
Price$454.36-11.49 (-2.47%)
2026-03-042026-06-05
News · 26 weeks42+43%
2025-12-142026-06-07
Mix2790d
- Insider17(63%)
- SEC Filings7(26%)
- Earnings2(7%)
- Other1(4%)
Latest news
25 items- INSIDERNew insider Hansman Brad W. claimed ownership of 697 shares (SEC Form 3)3 - Medpace Holdings, Inc. (0001668397) (Issuer)
- SECSEC Form 8-K filed by Medpace Holdings Inc.8-K - Medpace Holdings, Inc. (0001668397) (Filer)
- INSIDERGeneral Counsel & Corp. Secy. Ewald Stephen P exercised 16,349 shares at a strike of $138.87 and sold $7,357,050 worth of shares (16,349 units at $450.00) (SEC Form 4)4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- SECSEC Form 8-K filed by Medpace Holdings Inc.8-K - Medpace Holdings, Inc. (0001668397) (Filer)
- INSIDERSEC Form 4 filed by Director Zander Dani S.4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- INSIDERSEC Form 4 filed by Director Mccarthy Cornelius P. Iii4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- INSIDERSEC Form 4 filed by Director Kraft Robert O.4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- INSIDERSEC Form 4 filed by Director Gwadry-Sridhar Femida H.4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- INSIDERSEC Form 4 filed by Director Davenport Fred B Jr4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- INSIDERSEC Form 4 filed by Director Carley Brian T4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- INSIDERSEC Form 4 filed by CEO Troendle August J.4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- INSIDERGeneral Counsel & Corp. Secy. Ewald Stephen P exercised 3,500 shares at a strike of $138.87, increasing direct ownership by 21% to 20,343 units (SEC Form 4)4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- INSIDERSEC Form 4 filed by Exec. VP, Operations Burwig Susan E4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- INSIDERCFO & Treasurer Brady Kevin M. exercised 7,000 shares at a strike of $138.87, increasing direct ownership by 120% to 12,830 units (SEC Form 4)4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- SECSEC Form 10-Q filed by Medpace Holdings Inc.10-Q - Medpace Holdings, Inc. (0001668397) (Filer)
- SECMedpace Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits8-K - Medpace Holdings, Inc. (0001668397) (Filer)
- PRMedpace Holdings, Inc. Reports First Quarter 2026 ResultsRevenue of $706.6 million in the first quarter of 2026 increased 26.5% from revenue of $558.6 million for the comparable prior-year period, representing a backlog conversion rate of 23.3%. Net new business awards were $618.4 million in the first quarter of 2026, representing an increase of 23.7% from net new business awards of $500.0 million for the comparable prior-year period, which resulted in a net book-to-bill ratio of 0.88x. First quarter of 2026 GAAP net income was $123.9 million, or $4.28 per diluted share, versus GAAP net income of $114.6 million, or $3.67 per diluted share, for the comparable prior-year period. Net income margin was 17.5% and 20.5% for the first quarter of
- INSIDERSEC Form 4 filed by Mccarthy Cornelius P. Iii4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- INSIDERSEC Form 4 filed by Kraft Robert O.4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- INSIDERSEC Form 4 filed by Carley Brian T4 - Medpace Holdings, Inc. (0001668397) (Issuer)
- SECSEC Form DEFA14A filed by Medpace Holdings Inc.DEFA14A - Medpace Holdings, Inc. (0001668397) (Filer)
- SECSEC Form DEF 14A filed by Medpace Holdings Inc.DEF 14A - Medpace Holdings, Inc. (0001668397) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Medpace Holdings Inc.SCHEDULE 13G/A - Medpace Holdings, Inc. (0001668397) (Subject)
- PRMedpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026Medpace Holdings, Inc. (NASDAQ:MEDP) ("Medpace") today announced that it will report its first quarter 2026 financial results after the market close on Wednesday, April 22, 2026. The Company will host a conference call the following morning, Thursday, April 23, 2026, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is recommended you join 10 minutes prior to the event start. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique PIN that can be
- INSIDERSEC Form 4 filed by Burwig Susan E4 - Medpace Holdings, Inc. (0001668397) (Issuer)
MEDP FAQ
7 questionsWhat does Medpace Holdings Inc. do?
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and...Where does MEDP stock trade?
Medpace Holdings Inc. (MEDP) is listed on NASDAQ.What sector and industry is MEDP in?
Medpace Holdings Inc. operates in the Health Care sector, Biotechnology: Commercial Physical & Biological Resarch industry.When did Medpace Holdings Inc. go public?
Medpace Holdings Inc. (MEDP) completed its IPO in 2016.What are analysts saying about MEDP?
Medpace Holdings Inc. has had 8 recent analyst actions on file. The most recent action was from Barclays: Equal Weight on 2026-03-06.What companies are similar to MEDP?
Notable peers in the same industry include IQV (IQVIA Holdings Inc.), INCY (Incyte Corp.), PPD (PPD, Inc.), ICLR (ICON plc), SYNH (Syneos Health Inc.). Compare MEDP side-by-side with any of them on Quantisnow.How can I track MEDP on Quantisnow?
Quantisnow aggregates Medpace Holdings Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MEDP to receive live email and push alerts on every new disclosure.